Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cell cycle progression machinery refers to the network of molecular components that regulate and drive the orderly sequence of events leading to cell division. This machinery ensures accurate DNA replication, segregation of genetic material, and cytokinesis, resulting in two genetically identical daughter cells. The process is tightly regulated to maintain genomic integrity and respond appropriately to internal and external cues. Key components include cyclin-dependent kinases (CDKs), cyclins, ubiquitin ligase complexes (SCF and APC/C), retinoblastoma protein (Rb), and E2F transcription factors. Dysfunction or deregulation contributes directly to tumorigenesis. Many cancers harbor mutations affecting core components such as pRb pathway elements or overexpressing certain cyclins/CDKs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell Cycle Progression Machinery.